Skip to content

Compass Device CVC Trial

Central Venous Catheterization in Obese Patients With Compass Device

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03056859
Enrollment
20
Registered
2017-02-17
Start date
2017-02-17
Completion date
2020-02-10
Last updated
2024-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure

Keywords

Operator satisfaction with device

Brief summary

This is a single-arm observational trial of a device (Compass Vascular Access, Centurion Medical Products, Williamston MI). The device is a compact, sterile, single-use extravascular blood pressure transducer. This pressure measurement aids in confirmation of appropriate venous access. The investigators plan to enroll 40 consenting patients with BMI ≥35 who require central venous catheterization for clinical reasons independent of the existence of this study. The primary outcome is operator satisfaction.

Detailed description

Forty (40) consenting patients meeting inclusion/exclusion criteria for this single-arm observational trial will be prepared as usual for central venous catheter (CVC) placement. The Compass pressure measurement device will be included in the CVC placement apparatus as per the manufacturer's directions. Data will be recorded on the placement procedure, operator satisfaction, routine patient demographics, and incidence of inadvertent arterial puncture.

Interventions

DEVICEExtravascular blood pressure transducer

Listed device is included in central venous catheter placement apparatus for consenting patients, according to manufacturer directions

Sponsors

Centurion Medical Products
CollaboratorINDUSTRY
University of New Mexico
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* BMI ≥35

Exclusion criteria

* Pregnant women * Adults unable to consent * Non-English speakers * Prisoners

Design outcomes

Primary

MeasureTime frameDescription
Operator Satisfaction15 minutesOperator satisfaction (0-10 scale; 0=totally dissatisfied, 10=totally satisfied)

Secondary

MeasureTime frameDescription
Arterial Puncture Incidence15 minutesIncidence of arterial puncture
Implement Used at Time of Arterial Puncture, if Any15 minutesIf arterial puncture occurred, list catheterization implement being manipulated at the time

Countries

United States

Participant flow

Participants by arm

ArmCount
Enrolled Patients
Procedure: Central venous catheter placement with extravascular blood pressure transducer
20
Total20

Baseline characteristics

CharacteristicEnrolled Patients
Age, Continuous64 years
Body Mass Index39.6 kg/m^2
Race and Ethnicity Not Collected— Participants
Region of Enrollment
United States
20 participants
Sex: Female, Male
Female
10 Participants
Sex: Female, Male
Male
10 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 20
other
Total, other adverse events
0 / 20
serious
Total, serious adverse events
0 / 20

Outcome results

Primary

Operator Satisfaction

Operator satisfaction (0-10 scale; 0=totally dissatisfied, 10=totally satisfied)

Time frame: 15 minutes

ArmMeasureValue (MEDIAN)
Enrolled PatientsOperator Satisfaction8 score on a scale
Secondary

Arterial Puncture Incidence

Incidence of arterial puncture

Time frame: 15 minutes

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Enrolled PatientsArterial Puncture Incidence0 Participants
Secondary

Implement Used at Time of Arterial Puncture, if Any

If arterial puncture occurred, list catheterization implement being manipulated at the time

Time frame: 15 minutes

Population: There were no arterial punctures observed during the study.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026